
Tempus has announced that the US Food and Drug Administration (FDA) has granted it Breakthrough Device Designation for its HLA-LOH …

Canadian smartphone maker Blackberry is entering the healthcare arena with a cancer diagnostic tool aimed at doctors and nurses. Via …
Roche has obtained a worldwide sub-license from Genzyme to develop a diagnostic kit for the detection of specific mutations for …

A new report says the market for personalised medicine products is set to grow strongly over the next few years, …
An imaging agent that can detect amyloid plaques in the brains of Alzheimer’s patients and so may provide an accurate …